| Filed On | Filing |
|---|---|
| 23 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On October 21, 2026, the Board of Directors of Retension Pharmaceuticals, Inc. (the “Company” or “Retension”) appointed Robert Wong as Vice President, Chief Accounting Officer (Principal Accounting Officer) of the Company, effective as o... |
| 13 Oct 2026 |
8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The address of the registered office of Retension Pharmaceuticals, Inc. (the “Corporation”) in the State of Delaware, and the name of its registered agent at such address, shall be as set forth in the Corporation’s certificate of incorpo... |
Loading...
